a moment of boredom I came across the latest release of 'the Street.com's Biotech Mailbag,' a biotech column where readers interact with the host, Adam Feuerstein, by sending in questions about biotech stocks which Feuerstein answers in the form of his column.
I used to follow the mailbag every week, just as I used to watch Jim Cramer's CNBC show 'Mad Money', but it didn't take me long to realize that both Cramer and Feuerstein had their own agenda- and looking out for the little guy wasn't part of it.
...